SENSEX NIFTY

Cholesterol

Mar 27, 2014 at 18:59 | Source: PTI
The company's product is the generic equivalent of Pfizer Inc's Caduet tablets, it added. The Hyderabad-based firm's Amlodipine Besylate and Atorvastatin Calcium tablets are available in bottle counts of 30 and 90, the company said.
Mar 14, 2014 at 19:47 | Source: Moneycontrol.com
SC issues notice to Ranbaxy on plea to ban cholesterol drug
Mar 05, 2014 at 18:21 | Source: CNBC-TV18
Siddharth claims that Radikal rice is low on fat, has zero cholesterol, is gluten free and boasts of healthy carbohydrates.
Nov 08, 2013 at 08:48 | Source: Reuters
Partially hydrogenated oils, the primary dietary source of the fats, have been shown to raise "bad" cholesterol. Reducing the use of trans fats could prevent 20,000 heart attacks and 7,000 deaths from heart disease a year, the FDA said.
May 20, 2013 at 11:42 | Source: Moneycontrol.com
Lupin limited is the second company which launched the generic version of anti-cholesterol drug Tricor in November 2012. Tricor is a fairly big contributor to Lupin's profits.
May 20, 2013 at 11:12 | Source: Reuters
Mylan Inc said in a statement on Friday its unit Mylan Pharmaceuticals Inc has shipped generic Tricor, or fenofibrate tablets, of 48 mg and 145 mg. Mylan compete against Lupin, which also sells generic versions of Tricor.
May 08, 2013 at 15:16 | Source: Moneycontrol.com
Ranbaxy's first quarter consolidated net profit plunged 90 percent to Rs 126 crore, while net sales fell 34 percent to Rs 2,439.8 crore in Jan-March. The company's earnings in the year ago quarter were boosted by launch of generic version of cholesterol lowering drug Lipitor.
May 08, 2013 at 14:13 | Source: Reuters
Ranbaxy Laboratories, India's largest drugmaker by sales, reported a 90 percent drop in first quarter net profit compared to the same year-ago period, when it had exclusive rights to a generic version of cholesterol lowering drug Lipitor in the United States.
Apr 25, 2013 at 14:51 | Source: Reuters
Thousands of heart attack victims every year have none of the notorious risk factors before their crisis - not high cholesterol, not unhealthy triglycerides. Now the search for the mystery culprits has turned up some surprising suspects: the trillions of bacteria and other microbes living in the human gut.
Feb 27, 2013 at 10:50 | Source: Moneycontrol.com
Ranbaxy shares tumbled 4 percent on Wednesday morning, extending Tuesday's losses on a surprise fourth quarter loss on the back of falling sales and costs related to the recall of its cholesterol lowering drug in the US market.
Messages on Cholesterol »

countryman

Platinum Member

462 Followers

Avanti Feeds  

Interesting info: July 1, 2014 United States Myth Busters—Cholesterol and Shrimp Shrimp has long gotten a bad rap as a source of cholesterol. A three-ounce serving of shrimp has about 170 milligrams of dietary cholesterol, which is about 57% of a person’s daily recommended intake. By comparison

7.24 PM Jul 2nd

lighter1983

New Member

9 Followers

Prakash Constrowell  

u really enjoy bashin this stock huh lol. why dont u quit it.. take a chill pill. do yoga. lower down the cholesterol and go on a protein diet.. its for ur own good.

11.41 AM Jul 2nd

abrac

Platinum Member

173 Followers

FCS Software  

@ guest ji, u r on the dot. I m waiting for that day. Meanwhile, make hay while the sun shines. If u ve an I/d it wud have been better. Because, like good cholesterol and bad cholesterol in blood, here too, there are a couple of good guests and many......

7.57 PM Jun 18th

Lovely Mahendra

New Member

14 Followers

Commodities  

Indian Pharma Companies Recall Diabetes And Cholesterol Medicines

6.48 PM Mar 11th

chikly

Gold Member

18 Followers

Lupin  

), Triplix (cholesterol lowering), Cymbalta (anti-depressant drug) and Zymaxid (antibacterial eye drops). Zymaxid and Triplix generics are likely to see limited competition even after the 180-day exclusivity ends. Cymbalta has seen its market share increase by 30 basis points, to 11.5%, show recent data

9.29 PM Mar 10th

Web Messenger

Platinum Member

235232 Followers

Sun Pharma  

Source:Bloomberg - Sun Pharma is recalling a batch of generic diabetes tablets after a customer complained of finding pills of an epilepsy medication mixed in. Separately, rival Ranbaxy pulled two batches of its version of Pfizer Inc. (PFE)'s Lipitor cholesterol-lowering

6.52 PM Mar 10th

Web Messenger

Platinum Member

235232 Followers

Ranbaxy Labs  

Source:NDTV Profit - Drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, US regulators said. Ranbaxy recalled tablets of atorvastatin

1.25 PM Mar 10th

Web Messenger

Platinum Member

235232 Followers

Ranbaxy Labs  

Source:NDTV Profit - Mumbai: Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up

1.12 PM Mar 10th

Web Messenger

Platinum Member

235232 Followers

Ranbaxy Labs  

Source:Bloomberg - Ranbaxy Laboratories Ltd. (RBXY), India's largest drugmaker, has recalled two batches of the company's generic version of Pfizer Inc. (PFE)'s cholesterol-lowering medicine Lipitor after a dose mix-up was detected. Ranbaxy, a unit of Tokyo-based Daiichi 

1.11 PM Mar 10th

Web Messenger

Platinum Member

235232 Followers

Ranbaxy Labs  

Source:NDTV Profit - Mumbai: Shares in Ranbaxy Laboratories Ltd fell as much as 3.8 per cent on Monday after the drug maker recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.

11.56 AM Mar 10th

News across the web »
Aug 21, 2014 at 13:34 | Source: FirstPost
Aug 05, 2014 at 05:02 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.